Osteogenic potential using a malleable, biodegradable composite added traditional Chinese medicine: In vitro and in vivo evaluations

American Journal of Chinese Medicine

Volumn 34, Issue 5, 2006, Pages 873-886

  Yao, Chun Hsu ^a   Liu, Bai Shuan ^a   Liu, Chau Guey ^b   Chen, Yueh Sheng ^b  

^a CENTRAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Animal model; Biodegradable; Cell culture; Composites; Gui Lu Jiao (Colla Cornus Cervi and Colla Plastri Testudinis); Osteogenesis

Indexed keywords

BIOMATERIAL; CALCIUM PHOSPHATE CERAMIC; GELATIN; GIU LU JIAO; GLUTARALDEHYDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIODEGRADABILITY; BONE DEVELOPMENT; BONE GROWTH; BONE PROSTHESIS; CALVARIA; CELL CULTURE; CELL PROLIFERATION; CHINESE MEDICINE; COMPOSITE MATERIAL; CONTROLLED STUDY; FEASIBILITY STUDY; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; OSTEOBLAST; RABBIT; RAT; SKULL DEFECT;

ALKALINE PHOSPHATASE; ANIMALS; BIOCOMPATIBLE MATERIALS; BONE REGENERATION; BONE SUBSTITUTES; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; FEASIBILITY STUDIES; IMPLANTS, EXPERIMENTAL; MEDICINE, CHINESE TRADITIONAL; OSTEOBLASTS; OSTEOGENESIS; RABBITS; RATS; SKULL;

EID: 33750464892     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0192415X06004351     Document Type: Article

References (28)

1. Akamine, T., W.S. Jee, H.Z. Ke, X.J. Li and B.Y. Lin. Prostaglandin E2 prevents bone loss and adds extra bone to immobilized distal femoral metaphysis in female rats. Bone 13: 11-22, 1992.
2. Chen, T.M., C.H. Yao, H.J. Wang, G.H. Chou, T.W. Lee and F.H. Lin. Evaluation of a novel malleable, biodegradable osteoconductive composite in a rabbit cranial defect model. Mater. Chem. Phys. 55: 44-50, 1998.
3. Chenu, C., N. Kurihara, G. Mundy and D. Roodman. Prostaglandin E2 inhibits formation of osteoclast like cells in long-term human marrow cultures but is not a mediator of the inhibitory effects of transforming growth factor beta. J. Bone Miner. Res. 5: 677-681, 1990.
4. Ciapetti, G., L. Ambrosio, L. Savarino, D. Granchi, E. Cenni, N. Baldini, S. Pagani, S. Guizzardi, F. Causa and A. Giunti. Osteoblast growth and function in porous poly ε-caprolactone matrices for bone repair: A preliminary study. Biomaterials 24: 3815-3824, 2003.
5. Damien, J.C. and J.R. Parson. Bone graft and bone graft substitutes: A review of current technology and applications. J. Appl. Biomater. 2: 187-208, 1991.
6. Feng, J.Q., D. Chen, J. Esparza, M.A. Harris, G.R. Mundy and S.E. Harris. Deer antler contains two types of bone morphogenetic protein 4 mRNA transcripts. Biochim. Biophys. Acta 1263: 163-168, 1995.
7. Frame, J.W. A convenient animal model for testing bone substitute materials. J. Oral Surg. 38: 176-180, 1980.
8. Grynpas, M.D., R.M. Pilliar, R.A. Kandel, R. Renlund, M. Filiaggi and M. Dumitriu. Porous calcium polyphosphate scaffolds for bone substitute applications in vivo studies. Biomaterials 23: 2063-2070, 2002.
9. Harvey, W.K., J.L. Pincock and V.J. Matukas. Evaluation of subcutaneously implanted hydroxyapatiteavitene mixture in rabbits. J. Oral Maxillofac. Surg. 43: 277-284, 1993.
10. Hofman, S., M. Sidqui, D. Abensur, P. Valentini and P. Missika. Effects of Laddec on the formation of calcified bone matrix in rat calvariae cells culture. Biomaterials 20: 1155-1166, 1999.
11. Holmes, R., R. Bucholz and V. Mooney. Porous hydroxyapatite as a bone-graft substitute in metaphyseal defects, a histometric study. J. Bone Joint Surg. 68A: 904-909, 1986.
12. Ito, H., H.Z. Ke, W.S. Jee and Sakou T. Anabolic responses of anf adult cancellous bone site to prostaglandin E2 in the rat. Bone Miner. 21: 219-236, 1993.
13. Kocialkowski, A., W.A. Wallace and R.G. Burwell. Collagraft combined with autogeneic bone marrow: Experimental and clinical results. In: M.R. Urist, B.T. O'Connor and R.G. Burwell (eds.) Bone Grafts, Derivatives and Substitutes. Butterworth-Heinemann Ltd., London, 1994, pp. 271-290.
14. Lee, J.Y., S.H. Nam, S.Y. Im, Y.J. Park, Y.M. Lee, Y.J. Seol, C.P. Chung and S.J. Lee. Enhanced bone formation by controlled growth factor delivery from chitosan-based biomaterials. J. Control Release 78: 187-197, 2002.
15. Lin, C.Y., J.S. Sun, S.Y. Sheu, F.H. Lin, Y.J. Wang and L.T. Chen. The effect of Chinese medicine on bone cell activities. Am. J. Chin. Med. 30: 271-285, 2002.
16. Lin, F.H., C.H. Yao, J.S. Sun, H.C. Liu and C.W. Huang. Biological effects and cytotoxicity of the composite composed by tricalcium phosphate and glutaraldehyde cross-linked gelatin. Biomaterials 19: 905-917, 1998.
17. Lin, F.H., G.C. Dong, K.S. Chen, G.J. Jiang, C.W. Huang and J.S. Sun. Immobilization of Chinese herbal medicine onto the surface-modified calcium hydrogenphosphate. Biomaterials 24: 2413-2422, 2003.
18. 5 system. J. Biomed. Eng. 133: 328-334, 1991.
19. Liu, B.S., C.H. Yao, Y.S. Chen and S.H. Hsu. In vitro evaluation of degradation and cytotoxicity of a novel composite as a bone substitute. J. Biomed. Mater. Res. 67A: 1163-1169, 2003.
20. Liu, H.C., C.H. Yao, J.S. Sun, C.J. Lee, C.W. Huang and F.H. Lin. Osteogenic evaluation of glutaraldehyde crosslinked gelatin composite with fetal rat calvarial model. Artif. Organs 25: 644-654, 2001.
21. Manson, P.N., W.A. Crawley and J.E. Hoopes. Frontal cranioplasty: Risk factors and choice of cranial vault reconstructive material. Plast. Reconstr. Surg. 77: 888-900, 1986.
22. Norrdin, R.W., W.S.S. Jee and W.B. High. The role of prostaglandins in bone in vivo. Prostaglandins Leukot. Essent. Fatty Acids 41: 139-149, 1990.
23. Ongpipattanakul, B., T. Nguyen, T.F. Zioncheck, R. Wong, G. Osaka, L. DeGuzman, W.P. Lee and L.S. Beck. Development of tricalcium phosphate/ amylopectin paste combined with recombinant human transforming growth factor beta 1 as a bone defect filler. J. Biomed. Mater. Res. 36: 295-305, 1997.
24. Rawling, C.E., R.H. Wilkins and J.S. Hanker. Evaluation in cats of new material for cranioplasty: A composite of plaster of paris and hydroxyapatite. J. Neurosurg. 69: 269-275, 1988.
25. Schmitz, J.P. and J.O. Hollinger. The critical size defect as an experimental model for craniomandibulofacial nonunions. Clin. Ortho. Rel. Res. 20: 365-368, 1975.
26. Sunwoo, H.H., T. Nakano and J.S. Sim. Effect of water-soluble extract from antler of wapiti (Cervus elaphus) on the growth of fibroblasts. Can. J. Anim. Sci. 77: 343-345, 1997.
27. Suttie, J.M., P.F. Fennessy, S.R. Haines, M. Sadighi, D.R. Kerr and C. Isaacs. The New Zealand velvet antler industry: Background and research findings. In: International Symposium on Cervi Parvum Cornu. The Korean Society of Pharmacognosy, Seoul Korea, 1994, pp. 85-135.
28. Yao, C.H., C.C. Tsai, Y.S. Chen, C.J. Chang, B.S. Liu, C.C. Lin and Y.H. Tsuang. Fabrication and evaluation of a new composite composed of tricalcium phosphate, gelatin, and Chi-Li-Saan as a bone substitute. Am. J. Chin. Med. 30: 471-482, 2002.